No such discussions have taken place. The National Institute for Health and Clinical Excellence (NICE) has recently consulted on its plans to review its guidance on drug-eluting stents for the treatment of coronary artery disease. As a stakeholder, the Department has responded to that consultation. It is understood that NICE is considering the responses to its consultation exercise and will make a decision on the proposed review in due course.